STOCKWATCH
·
Major Chemicals
Quarterly ResultMay 1, 2026, 10:46 AM

LIN Q1 Sales +8.2% to $8.78B; EPS +13.3% to $4.00

AI Summary

Linde PLC reported strong first-quarter 2026 results with sales increasing 8.2% to $8.78 billion and diluted earnings per share rising 13.4% to $3.98. Net income attributable to Linde plc grew 11.0% to $1.86 billion, and net cash from operating activities increased to $2.24 billion. The company also repaid $725 million in notes, reducing total debt. However, Linde continues to face complex legal proceedings in Russia, including a $1.1 billion contingent liability, and an appeal in the Linde AG appraisal proceedings.

Key Highlights

  • LIN Q1 Sales increased 8.2% to $8.78 billion from $8.11 billion YoY.
  • LIN Q1 Net Income attributable to Linde plc rose 11.0% to $1.86 billion.
  • LIN Q1 Diluted EPS grew 13.4% to $3.98 from $3.51 YoY.
  • Net cash provided by operating activities increased to $2.24 billion.
  • Repaid $725 million of 3.20% notes due 2026 in January.
  • Total debt decreased to $26.32 billion from $26.99 billion at Dec 31, 2025.
  • Ongoing legal disputes in Russia with a contingent liability of $1.1 billion.
  • Plaintiffs appealed the court's rejection of Linde AG cash merger squeeze-out claims.
LIN
Major Chemicals
LINDE PLC

Price Impact